The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
cGMPs
GlaxoSmithKline Bribery Scandal: Sexual Favors to Increase Sales?
China continues to step up its probe into alleged bribery by British drugmaker GlaxoSmithKline to illegally boost sales and inflate the price of its medicines.
July 18, 2013
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Fujifilm Biotechnologies to leverage downstream purification system at UK site
‘Cobots’ drive pharma’s shift toward scalable cell therapies
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Trending
Eli Lilly plans to invest $6B in new API manufacturing facility in Alabama
Q&A: Inside Cambrex’s expansion, strategic focus in 2025 and beyond
Manufacturing, supply chain risks in 2026 will continue to weigh on life sciences
Sponsored Picks
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
AI-Powered QMS: The Future of Quality Management
Load More Content
